Rimon

Entries tagged “proposition 65green chemistry”

Insights on the Decline (and Possible Rise) in New Medical, Pharma Filings in Federal Court

insights April 4, 2018

Rimon’s complex litigator, Dennis Raglin, was quoted in the New York Law Journal on the recent decline of medical device and pharmaceutical litigation filings.  He believes these filings ebb and flow due to various factors, including the economy, state tort reform, and how judges rule on motions that impact future cases, as well as whether drug…

Continue Reading…